Effect of Itopride on Semaglutide Gastroparesis
Recruiting
Phase 4
Interventional Study
Semaglutide-Induced Gastric Motility
Anesthesia
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 40 – 60
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 60 (estimated)
- Sponsor
- Ain Shams University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Semaglutide delays gastric emptying and increases the risk of aspiration with anesthesia; So, the addition of prokinetics as Itopride, could enhance gastric emptying and hasten surgery. The investigator will evaluate the effect of Itopride on Semaglutide-induced gastroparesis and residual gastric contents after 8 hours of fasting by gastric ultrasound before anesthesia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* American Society of Anesthesiologists grade I- III.
* Age: 40-60 years.
* BMI: 20-30 kg/m2.
* Diabetic patients on semaglutide (0.5-1mg) SC weekly.
* Undergoing elective hysterectomy.
Exclusion Criteria:
* Declining to give written informed consent.
* history of upper abdomi…
Contacts